As of Oct 08
| -0.18 / -4.04%|
The 8 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 14.50, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +239.58% increase from the last price of 4.27.
The current consensus among 9 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.